These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19398283)

  • 1. The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study.
    Franklin TR; Harper D; Kampman K; Kildea-McCrea S; Jens W; Lynch KG; O'Brien CP; Childress AR
    Drug Alcohol Depend; 2009 Jul; 103(1-2):30-6. PubMed ID: 19398283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
    Cousins MS; Stamat HM; de Wit H
    Nicotine Tob Res; 2001 May; 3(2):123-9. PubMed ID: 11403726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers.
    Leggio L; Zywiak WH; Edwards SM; Tidey JW; Swift RM; Kenna GA
    Psychopharmacology (Berl); 2015 Jan; 232(1):233-43. PubMed ID: 24973894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Trial Comparing the Effect of Nicotine Versus Placebo Electronic Cigarettes on Smoking Reduction Among Young Adult Smokers.
    Tseng TY; Ostroff JS; Campo A; Gerard M; Kirchner T; Rotrosen J; Shelley D
    Nicotine Tob Res; 2016 Oct; 18(10):1937-1943. PubMed ID: 26783292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
    BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nondaily Smokers' Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical Trial.
    Shiffman S; Kurland BF; Scholl SM; Mao JM
    JAMA Psychiatry; 2018 Oct; 75(10):995-1002. PubMed ID: 29902305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings.
    Morgan CJ; Das RK; Joye A; Curran HV; Kamboj SK
    Addict Behav; 2013 Sep; 38(9):2433-6. PubMed ID: 23685330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two weeks of image-guided left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation improves smoking cessation: A double-blind, sham-controlled, randomized clinical trial.
    Li X; Hartwell KJ; Henderson S; Badran BW; Brady KT; George MS
    Brain Stimul; 2020; 13(5):1271-1279. PubMed ID: 32534252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of resting brain cerebral blood flow by the GABA B agonist, baclofen: a longitudinal perfusion fMRI study.
    Franklin TR; Wang Z; Sciortino N; Harper D; Li Y; Hakun J; Kildea S; Kampman K; Ehrman R; Detre JA; O'Brien CP; Childress AR
    Drug Alcohol Depend; 2011 Sep; 117(2-3):176-83. PubMed ID: 21333466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals.
    Kahn R; Biswas K; Childress AR; Shoptaw S; Fudala PJ; Gorgon L; Montoya I; Collins J; McSherry F; Li SH; Chiang N; Alathari H; Watson D; Liberto J; Beresford T; Stock C; Wallace C; Gruber V; Elkashef A
    Drug Alcohol Depend; 2009 Jul; 103(1-2):59-64. PubMed ID: 19414226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
    Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.
    Shoptaw S; Yang X; Rotheram-Fuller EJ; Hsieh YC; Kintaudi PC; Charuvastra VC; Ling W
    J Clin Psychiatry; 2003 Dec; 64(12):1440-8. PubMed ID: 14728105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.
    Weinberger AH; Reutenauer EL; Jatlow PI; O'Malley SS; Potenza MN; George TP
    Drug Alcohol Depend; 2010 Mar; 107(2-3):188-95. PubMed ID: 19939587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.
    Winhusen TM; Somoza EC; Brigham GS; Liu DS; Green CA; Covey LS; Croghan IT; Adler LA; Weiss RD; Leimberger JD; Lewis DF; Dorer EM
    J Clin Psychiatry; 2010 Dec; 71(12):1680-8. PubMed ID: 20492837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Varenicline for Smoking Cessation in Alcohol-Dependent Smokers in Concurrent Treatment for Alcohol Use Disorder: A Pilot, Randomized Placebo-Controlled Trial.
    Zawertailo L; Ivanova A; Ng G; Le Foll B; Selby P
    J Clin Psychopharmacol; 2020; 40(2):130-136. PubMed ID: 32068562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.
    Piper ME; Smith SS; Schlam TR; Fiore MC; Jorenby DE; Fraser D; Baker TB
    Arch Gen Psychiatry; 2009 Nov; 66(11):1253-62. PubMed ID: 19884613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581].
    Assadi SM; Radgoodarzi R; Ahmadi-Abhari SA
    BMC Psychiatry; 2003 Nov; 3():16. PubMed ID: 14624703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.